ATAI
Price
$1.12
Change
+$0.08 (+7.69%)
Updated
Dec 1, 6:59 PM EST
115 days until earnings call
CABA
Price
$16.02
Change
-$0.03 (-0.19%)
Updated
Dec 1, 6:59 PM EST
102 days until earnings call
Ad is loading...

ATAI vs CABA ᐉ Comparison: Which is Better to Invest?

Header iconATAI vs CABA Comparison
Open Charts ATAI vs CABABanner chart's image
ATAI Life Sciences
Price$1.12
Change+$0.08 (+7.69%)
Volume$520.97K
CapitalizationN/A
Cabaletta Bio
Price$16.02
Change-$0.03 (-0.19%)
Volume$718.64K
CapitalizationN/A
View a ticker or compare two or three
ATAI vs CABA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ATAI vs. CABA commentary
Dec 04, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a StrongSell and CABA is a Buy.

COMPARISON
Comparison
Dec 04, 2023
Stock price -- (ATAI: $1.12 vs. CABA: $16.02)
Brand notoriety: ATAI and CABA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 169% vs. CABA: 123%
Market capitalization -- ATAI: $179.29M vs. CABA: $801.28M
ATAI [@Biotechnology] is valued at $179.29M. CABA’s [@Biotechnology] market capitalization is $801.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileCABA’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • CABA’s FA Score: 0 green, 5 red.
According to our system of comparison, CABA is a better buy in the long-term than ATAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 6 TA indicator(s) are bullish while CABA’s TA Score has 6 bullish TA indicator(s).

  • ATAI’s TA Score: 6 bullish, 2 bearish.
  • CABA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than CABA.

Price Growth

ATAI (@Biotechnology) experienced а +1.82% price change this week, while CABA (@Biotechnology) price change was -14.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +30.64%, and the average quarterly price growth was +27.15%.

Reported Earning Dates

ATAI is expected to report earnings on Mar 27, 2024.

CABA is expected to report earnings on Mar 14, 2024.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ATAI with price predictions.
OPEN
A.I.dvisor published
a Summary for CABA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CABA($801M) has a higher market cap than ATAI($179M). CABA YTD gains are higher at: 73.189 vs. ATAI (-57.895). CABA (-66.37M) and ATAI (-67.3M) have comparable annual earnings (EBITDA) . ATAI has more cash in the bank: 209M vs. CABA (164M). CABA has less debt than ATAI: CABA (4.27M) vs ATAI (16.7M). ATAI has higher revenues than CABA: ATAI (334K) vs CABA (0).
ATAICABAATAI / CABA
Capitalization179M801M22%
EBITDA-67.3M-66.37M101%
Gain YTD-57.89573.189-79%
P/E RatioN/AN/A-
Revenue334K0-
Total Cash209M164M127%
Total Debt16.7M4.27M391%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAICABA
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
74%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIGIX19.120.20
+1.06%
Calamos International Growth I
HBLIX13.920.12
+0.87%
Hartford Balanced Income I
ESEIX31.980.23
+0.72%
Eaton Vance Atlanta Capital Sel Eq I
FLYCX31.310.20
+0.64%
Nuveen Large Cap Select C
HLEZX18.14N/A
N/A
Harding Loevner Instl Emerg Mkts Z

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with FATE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+7.69%
FATE - ATAI
55%
Loosely correlated
+6.43%
ANAB - ATAI
49%
Loosely correlated
+6.08%
COUR - ATAI
45%
Loosely correlated
+2.33%
ORMP - ATAI
45%
Loosely correlated
-4.05%
GRPH - ATAI
44%
Loosely correlated
-0.44%
More

CABA and

Correlation & Price change

A.I.dvisor tells us that CABA and CDTX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CABA and CDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+15.42%
CDTX - CABA
33%
Poorly correlated
+10.08%
ORMP - CABA
32%
Poorly correlated
-4.05%
ICVX - CABA
32%
Poorly correlated
+3.75%
PSTX - CABA
31%
Poorly correlated
-1.12%
IOVA - CABA
29%
Poorly correlated
+3.13%
More